ABVC (ABVC) Stock Price & Analysis
ABVC (ABVC) rose 3.08% to USD 0.99 as of September 8, 2026 at 14:04 UTC, according to Nexqual real-time market data.
ABVC last closed at USD 0.99; the session ranged USD 0.96–1.01 on volume of 22,259 shares. Market capitalization is —, with a 52-week range of USD 0.71–3.4 (NCM). Source: Nexqual, September 8, 2026 at 14:04 UTC.
Key Statistics (as of September 8, 2026 at 14:04 UTC)
| Price | USD 0.99 |
|---|---|
| Change | ▲ 3.08% (up) |
| Previous Close | USD 0.99 |
| Open | USD 0.99 |
| Day Range | USD 0.96 – 1.01 |
| 52-Week Range | USD 0.71 – 3.4 |
| Volume | 22,259 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ABVC)
Nexqual's technical model rates ABVC "SELL" based on 2 bullish and 4 bearish signals across 127 daily candles, as of September 8, 2026 at 14:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 52.89 (neutral) |
| vs SMA50 | Below (USD 1.14) |
| MACD | -0.04 (negative) |
Analyst Ratings (ABVC)
Wall Street analysts rate ABVC "None", per Nexqual as of September 8, 2026 at 14:04 UTC.
| Consensus Rating | None |
|---|
Earnings (ABVC)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2023-03-31 | USD -0.6 vs est -0.5 ▼ miss |
| 2022-12-31 | USD -1.5 vs est -1.5 ▲ beat |
| 2022-09-30 | USD -1.1 vs est -2 ▲ beat |
| 2022-06-30 | USD -0.6 vs est -1.25 ▲ beat |
Source: Nexqual, September 8, 2026 at 14:04 UTC.
Financials & Fundamentals (ABVC)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -69.86% |
| Debt / Equity | 23.53 |
| Current Ratio | 0.07 |
| Total Cash | $94,364 |
| Total Debt | $2.89M |
| Free Cash Flow | $1.56M |
Source: Nexqual, September 8, 2026 at 14:04 UTC.
Ownership (ABVC)
| Insider Ownership | +18.11% |
|---|---|
| Institutional Ownership | +4.09% |
| Shares Outstanding | 26.65M |
| Float | 21.10M |
| Short % of Float | +1.97% |
Source: Nexqual, September 8, 2026 at 14:04 UTC.
From ABVC's Latest SEC 10-K Filing (filed 2026-03-03)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBLG | Bone Biologics Corp | USD 0.58 | ▲ 3.41% |
| RNAZ | TransCode Therapeutics, Inc. | USD 2.03 | ▼ 5.8% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.41 | ▼ 6.11% |
| BTTX | Better Therapeutics, Inc. | USD 0 | ▲ 0% |
| EVAX | Evaxion A/S | USD 3.26 | ▲ 5.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:04 UTC. This page is informational and not investment advice.